Analysis of K-ras oncogene mutations in chronic pancreatitis with ductal hyperplasia

Surgery

Volumn 121, Issue 1, 1997, Pages 42-49

  Rivera, Jaime A ^b   Rall, Christopher J N ^b   Graeme Cook, Fiona ^b   Fernández Del Castillo, Carlos ^b   Shu, Pei ^b   Lakey, Nathan ^b   Tepper, Robert ^b   Rattner, David W ^b   Warshaw, Andrew L ^b   Rustgi, Anil K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA DETERMINATION; DNA SEQUENCE; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; MICROSCOPY; ONCOGENE K RAS; PANCREAS CANCER; PANCREAS DUCT; PANCREAS RESECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 12644290242     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90181-1     Document Type: Article

References (36)

1. Lillemoe KD. Current management of pancreatic carcinoma. Ann Surg 1995;221:133-48.
2. Warshaw AL, Fernández-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992;326:455-65.
3. Crist DW, Cameron JL. The current status of the Whipple operation for periampullary carcinoma. Adv Surg 1992;25:21-49.
4. Fernández-del Castillo C, Rattner DW, Warshaw AL. Standards for pancreatic resection in the 1990s. Arch Surg 1995;130:295-300.
5. Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Boitnott JK, Seidler AJ, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991;161: 121-5.
6. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, et al. Pancreatitis and the risk of pancreatic cancer. N Engl J Med 1993;328:1433-7.
7. Cubilla AL, Fitzgerald PJ. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res 1976;36:2690-8.
8. Sommers SC, Murphy SA, Warren S. Pancreatic duct hyperplasia and pancreatic cancer. Gastroenterology 1954;27:629-40.
9. Kozuka S, Sassa R, Taki T, Masamoto K, Nagasawa S, Saga S, et al. Relation of pancreatic duct hyperplasia to carcinoma. Cancer 1979;43:1418-28.
10. Kern HF. Fine structure of the human exocrine pancreas. In: Go VLW, Dimagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, editors. The pancreas: biology, pathobiology, and disease. 2nd ed. New York: Raven Press, 1993:9-20.
11. Krontiris TG. Molecular medicine: oncogenes. N Engl J Med 1995;333:303-6.
12. Motojima K, Urano T, Nagata Y, Shiku H, Tsurifune T, Kanematsu T. Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Ann Surg 1993;217:138-43.
13. Motojima K, Tsunoda T, Kanematsu T, Nagata Y, Urano T, Shiku H. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene. Ann Surg 1991;214:657-62.
14. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 1994;54:3568-73.
15. Hruban RH, van Mansfeld ADM, Offerhaus GJA, van Weering DHJ, Allison DC, Goodman SN, et al. K-ras oncogene activation in adenocarcinoma of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993;143:545-54.
16. Augustine P, Ramesh H. Is tropical pancreatitis premalignant? Am J Gastroenterol 1991;87:1005-8.
17. Chari ST, Mohan V, Pitchumoni CS, Viswanathan M, Madanagopalan N, Lowenfels AB. Risk of pancreatic carcinoma in tropical calcifying pancreatitis: an epidemiologic study. Pancreas 1994; 9:62-6.
18. Shah S, Amarapurkar D, Pitchumoni CS. Hereditary pancreatitis. Am J Gastroenterol 1994;89:928-30.
19. Little JM, Tait N, Richardson A, Dubois R. Chronic pancreatitis beginning in childhood and adolescence. Arch Surg 1992;127: 90-2.
20. Kloppel G. Pathology of nonendocrine pancreatic tumors. In: Go VLW, Dimagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, editors. The pancreas: biology, pathobiology, and disease. 2nd ed. New York: Raven Press, 1993:871-98.
21. Smit VTHBM, Boot AJM, Smits AMM, Fleuren GJ, Cornelisse CJ, Bos JL. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res 1988;16:7773-82.
22. Caldas C, Kern SE. K-ras mutation and pancreatic adenocarcinoma. Int J Pancreatol 1995;18:1-5.
23. Tada M, Omata M, Ohio M. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology 1991;100:233-8.
24. Lemoine NR, Jain S, Hughes CM, Staddon SL, Maillet B, Hall PA, et al. Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 1992;102:230-6.
25. Yanagisawa A, Ohtake K Ohashi K, Hori M, Kitagawa T, Sugano H, et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993;53:953-6.
26. Tada M, Ohashi M, Shiratori Y, Okudaira T, Komatsu Y, Kawabe T, et al. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 1996;110:227-31.
27. Rall CJN, Yan YX, Graeme-Cook CF, Beauchamp R, Yandell DW, Povoski SP, et al. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma. Pancreas 1995;12:10-7.
28. Kalthoff H, Schmiegel W, Roeder C, Rasche D, Schmidt A, Lauer G, et al. p53 and K-ras alterations in pancreatic epithelial cell lesions. Oncogene 1993;8:289-98.
29. INK4 mutadons. N Engl J Med 1995;333:970-4.
30. Whelan AJ, Bartsch D, Goodfellow PJ. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N Engl J Med 1995;333: 975-7.
31. Liu Q, Yan YX, McClure M, Nakagawa H, Fujimura F, Rustgi AK. MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines. Oncogene 1995;10:619-22.
32. Hahn SA, Schutte M, Shamsul Hoque ATM, da Costa LT, Rosenblum E, Weinstein CL, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-73.
33. Yamanka Y, Freiss H, Kobrin MS, Buchleer M, Beger HG, Korc M. Coespression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Res 1993;13:565-9.
34. Korc M, Chandrasekar B, Yamanka Y, Freiss H, Buchier M, Beger HG. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of EGFR and TGF alpha. J Clin Invest 1992; 90:1352-60.
35. Davies N, Kapur P, Gillespie J, Guillovp J, Poston GJ. Transforming growth factor alpha is trophic to pancreatic cancer in vivo. Gut 1993;34:1097-8.
36. Estival A, Clerc P, Vaysse N, Tam JP, Clemente F. Decreased expression of transforming growth factor alpha during differentiation of human pancreatic cancer cells. Gastroenterology 1992; 103:1851-9.